Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for DABUR.NS and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for DABUR.NS and 80,000+ other tickers.
See exactly how DABUR.NS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for DABUR.NS and 80,000+ other tickers.
Dabur India Limited functions as a leading global fast-moving consumer goods (FMCG) enterprise, conducting its operations through distinct Consumer Care Business, Foods Business, Retail Business, and Other segments. Its comprehensive product portfolio encompasses a diverse array of health supplements, such as Dabur Chyawanprash, Dabur Vita, Dabur Honey, Dabur Immunity Kit, Dabur Vedic Suraksha Tea, and Dabur Glucose. The company also offers digestive aids including Dabur Hajmola, Pudin Hara, Hingoli, Dabur Nature Care, and Sat Isabgol. In the realm of personal care, Dabur provides shampoos…
No recent news available.